Key Skills & Competencies
• Strong scientific acumen and therapy area understanding
• Strong understanding of India pharma market & Indian regulatory landscape
• Strong understanding of biosimilars clinical development,
• Strong financial acumen, analytics, forecasting and market assessment.
• Experience of execution of partnership deal agreements with strong legal acumen
• Excellent stakeholder management skills.
• Ability to synthesize complex scientific and commercial information into actionable insights.
• Strategic thinking, problem solving, and decision making.
• Strong communication and presentation skills.
________________________________________
Qualifications
• Master’s in Life Sciences / Pharmacy / Biotechnology/MBBS, MD; MBA or PHD preferred.
• 10+ years of experience in business development, portfolio management, in licensing, in the pharmaceutical/biotech industry.
• Proven track record of successful deal closures
________________________________________
Preferred Experience
• Experience working with big pharmaceutical companies in biologics/biosimilars portfolio development
• Exposure to multiple therapeutic areas
• Understanding of Indian and international regulatory & commercial landscapes.
________________________________________
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.
